UMass Chan Medical School

@umasschan.bsky.social

UMass Chan Medical School: pioneering education, research and healthcare delivery in Worcester, Mass. See how we are advancing medicine together. https://direc.to/mZJw #AdvancingTogether

Read Pukkila-Worley, MD, professor of medicine, has received a $3 million NIH award to test a hypothesis that host cells have evolved mechanisms to survey for the presence of an active infection rather than infectious bacteria: https://direc.to/pavc @rpwlab.bsky.social @umassmedicine.bsky.social

Read Pukkila-Worley receives $3 million NIH award for research on bacterial pathogenesis

The R01 grant will support research on how bacteria cause infectious diseases.

direc.to

Uruj Kamal Haider, MD, outlines three steps to connect patients at-risk for developing postpartum psychosis to care in this opinion piece published by @time.com: https://direc.to/papf Dr. Haider is an assistant professor of psychiatry & behavioral sciences at UMass Chan. #MentalHealth #postpartum

Postpartum Psychosis Is Rising. We Are Not Ready.

Early screening can serve as prevention, but only if we connect at-risk patients to care, writes Dr. Uruj Kamal Haider.

direc.to

UMass Chan researcher Michelle K. Trivedi, MD’09, MPH, is leading the largest nationwide study on the effectiveness of school-based health centers: https://direc.to/pao2 Determining if the centers reduce asthma exacerbations is part of the study. #HealthCare #research #asthma @uofmass.bsky.social

UMass Chan leading national study on school-based health centers

Michelle Trivedi, MD’09, MPH, received a $3.8 million grant from the National Institutes of Health to study school-based health centers.

direc.to

The FDA has given UMass Chan scientists the green light for a Phase I/II clinical trial of a second-generation gene therapy for GM2 gangliosidosis, a group of rare neurodegenerative disorders that includes Tay-Sachs disease and Sandhoff disease: https://direc.to/paf3 @blugenesfdn.bsky.social

UMass Chan researchers receive FDA authorization to advance gene therapy clinical trial for Tay-Sachs and Sandhoff diseases

FDA approves gene therapy clinical trial for Tay-Sachs and Sandhoff diseases by UMass Chan scientists

direc.to

With funds from the UMass Amherst Center for Data Science and Artificial Intelligence, UMass Chan and @umassamherst.bsky.social colleagues are developing #AI capable of identifying neuron types from images so scientists can study whole-brain activity: https://direc.to/o_c4 @manningcics.bsky.social

UMass Chan scientist receives award to develop AI capable of identifying neuron types

AI project at UMass Chan strives to identify different neuron types from 3D images and video

direc.to

Postdoctoral fellow Naomi Fettig, PhD, has received a Canada Postdoctoral Research Award, a two-year award that will support her research on the demyelination of multiple sclerosis—when the myelin that insulates and protects neurons is broken down and damaged: https://direc.to/oADH #MS #MSresearch

Naomi Fettig receives Canadian Institutes of Health Research award for multiple sclerosis research

UMass Chan scientist receives two-year, $140,000 Canada Postdoctoral Research Award for multiple sclerosis research.

direc.to

UMass Chan Medical School researchers are collaborating on a remote patient monitoring system for people with lupus. Read about the PILLAR project and the clinical trial that will be implemented in collaboration with UMass Memorial Health: https://direc.to/oARA #lupus @umassmedicine.bsky.social

Remote patient monitoring system in development to improve care for people with lupus

The project is funded for $3.5 million over seven years by the UMass Center for Clinical and Translational Science.

direc.to

MD/PhD student Melanie Barbini has received a predoctoral fellowship award from the NIH that could have implications for multiple sclerosis and Alzheimer’s patients. Read about why she credits mentors Dorothy Schafer, PhD, and Chancellor David McManus: https://direc.to/oBqo #StudentSpotlight

Fellowship award highlights Melanie Barbini’s mastery in research, clinical studies

Barbini credits her success to her co-mentors, Chancellor David McManus and Dorothy Schafer.

direc.to

UMass Chan and Elicio Therapeutics have teamed up to show how a new vaccine platform creates a robust immune response, opening up new avenues for vaccinations against pathogens such as malaria and tuberculosis: https://direc.to/oBZx #vaccine #immunity #malaria #TB @fitzgeraldkate.bsky.social

UMass Chan research shows exciting step forward in innate immune stimulation and vaccine platform development

AMP modified vaccine adjunct activates robust T cell response.

direc.to

The next chapter of UMass Chan Medical School has officially begun. David D. McManus, MD’02, ScM’12, MBA, stepped into the role of chancellor today, becoming the first alumnus to lead the institution. Get to know him here: direc.to/oCCB #UMass @uofmass.bsky.social @martymeehan.bsky.social

From medical student to chancellor: David McManus charts UMass Chan’s next chapter

David D. McManus, MD’02, ScM’12, MBA, has officially stepped into the role of chancellor of UMass Chan.

direc.to

PhD candidate Rebekka Anderson has received a grant from the NIH to support her research on how mutations in transporter proteins impact calcium wave intervals and how they could be linked to gout, a severe form of inflammatory arthritis: direc.to/oGeZ #NIH #grant #gout #PhDSky @uofmass.bsky.social

PhD candidate Rebekka Anderson receives fellowship award to study calcium waves in C. elegans, links to gout

The three-year predoctoral fellowship is funded by the National Institute of Diabetes and Digestive and Kidney Diseases.

direc.to